BR112012000679A2 - diagnóstico de uma doença parasitária como a leishmaniose utilizando um extrato de proteína ribossômica (epr) - Google Patents

diagnóstico de uma doença parasitária como a leishmaniose utilizando um extrato de proteína ribossômica (epr)

Info

Publication number
BR112012000679A2
BR112012000679A2 BR112012000679A BR112012000679A BR112012000679A2 BR 112012000679 A2 BR112012000679 A2 BR 112012000679A2 BR 112012000679 A BR112012000679 A BR 112012000679A BR 112012000679 A BR112012000679 A BR 112012000679A BR 112012000679 A2 BR112012000679 A2 BR 112012000679A2
Authority
BR
Brazil
Prior art keywords
leishmaniasis
epr
diagnosis
ribosomal protein
protein extract
Prior art date
Application number
BR112012000679A
Other languages
English (en)
Inventor
Carlos Alonso Bedate
Eduardo Antonio Ferraz Coelho
Laura Ramírez García
Manuel Soto Álvarez
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of BR112012000679A2 publication Critical patent/BR112012000679A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Secondary Cells (AREA)
BR112012000679A 2009-07-13 2010-07-13 diagnóstico de uma doença parasitária como a leishmaniose utilizando um extrato de proteína ribossômica (epr) BR112012000679A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09165282 2009-07-13
US26721409P 2009-12-07 2009-12-07
PCT/EP2010/060058 WO2011006891A1 (en) 2009-07-13 2010-07-13 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe)

Publications (1)

Publication Number Publication Date
BR112012000679A2 true BR112012000679A2 (pt) 2016-11-01

Family

ID=41211952

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012000679A BR112012000679A2 (pt) 2009-07-13 2010-07-13 diagnóstico de uma doença parasitária como a leishmaniose utilizando um extrato de proteína ribossômica (epr)

Country Status (20)

Country Link
US (1) US8969019B2 (pt)
EP (1) EP2454593A1 (pt)
JP (1) JP5805635B2 (pt)
KR (1) KR20120061082A (pt)
CN (1) CN102483413A (pt)
AP (1) AP3516A (pt)
AU (1) AU2010272566B2 (pt)
BR (1) BR112012000679A2 (pt)
CA (1) CA2767865A1 (pt)
CO (1) CO6480993A2 (pt)
EC (1) ECSP12011662A (pt)
IL (1) IL217528A (pt)
IN (1) IN2012DN00401A (pt)
MA (1) MA33514B1 (pt)
MX (1) MX2012000675A (pt)
PE (1) PE20120818A1 (pt)
RU (1) RU2558233C2 (pt)
TN (1) TN2012000014A1 (pt)
WO (1) WO2011006891A1 (pt)
ZA (1) ZA201200295B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
JP2016053535A (ja) * 2014-09-04 2016-04-14 国立大学法人 東京大学 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6613337B1 (en) * 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
EP1624063B1 (en) * 1998-12-23 2009-04-22 Laboratorios LETI, S.L. Chimeric gene encoding the antigenic determinants of four proteins of L. infantum
DE69940793D1 (de) * 1998-12-23 2009-06-04 Leti Sl Lab Chimärisches Gen, dass für die antigenischen Determinanten von vier Proteinen aus L. Infantum kodiert
ES2169995B1 (es) 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
AU2003270274B2 (en) * 2002-09-20 2009-03-19 Intervet International B.V. Live attenuated parasite vaccine
RS52507B (en) 2003-11-05 2013-04-30 Laboratorios Leti S.L. APPLICATION OF SPECIFIC HISTONS FOR THE TREATMENT OF PARASITIC DISEASES

Also Published As

Publication number Publication date
MA33514B1 (fr) 2012-08-01
AP3516A (en) 2016-01-11
ECSP12011662A (es) 2012-06-29
US20120178109A1 (en) 2012-07-12
PE20120818A1 (es) 2012-07-12
WO2011006891A1 (en) 2011-01-20
JP2012533074A (ja) 2012-12-20
CO6480993A2 (es) 2012-07-16
TN2012000014A1 (en) 2013-09-19
RU2558233C2 (ru) 2015-07-27
IL217528A0 (en) 2012-02-29
RU2012104855A (ru) 2013-08-20
CA2767865A1 (en) 2011-01-20
ZA201200295B (en) 2012-09-26
AU2010272566B2 (en) 2015-03-26
AU2010272566A1 (en) 2012-02-02
KR20120061082A (ko) 2012-06-12
AP2012006118A0 (en) 2012-02-29
IN2012DN00401A (pt) 2015-08-21
CN102483413A (zh) 2012-05-30
US8969019B2 (en) 2015-03-03
JP5805635B2 (ja) 2015-11-04
IL217528A (en) 2016-05-31
EP2454593A1 (en) 2012-05-23
MX2012000675A (es) 2012-06-08

Similar Documents

Publication Publication Date Title
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
BRPI1009197A2 (pt) preparação de ácido alfa-cetopimélico
BRPI1016112A2 (pt) bomba cardíaca
DK2321430T3 (da) Fremgangsmåde til at evaluere oral cancer riskiko hos mennesker
BRPI0910823A2 (pt) método para conduzir estudos de ecg para uma pluralidade de pacientes
BRPI1010307A2 (pt) composições e métodos relacionados à variantes de proteína a (spa).
DK2480218T3 (da) Syreresistente kapsler
SMT201400069B (it) Formulazione farmaceutica
BRPI1012539A2 (pt) composições farmacêuticas
DK2459117T3 (da) Kateter til transanal skylning
DK2645921T3 (da) Engangssugeventil til et endoskop
BRPI1008932A2 (pt) cápsula endoscópica
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
BRPI1008744A2 (pt) hidrotratamento de caboidratos
IT1394400B1 (it) Composizioni farmaceutiche
BRPI0925056A2 (pt) medicamento mastigável
DE112010000740A5 (de) Endoskop
DK2429902T3 (da) Batchopsamler
DK2780716T3 (da) Fremgangsmåde til diagnose af Niemann-Pick sygdom
BR112012001340A2 (pt) composições farmacêuticas
BRPI1011554A2 (pt) Melhora do rendimento de plantas de cultivo através da seleção de populações epigeneticamente modificadas
BRPI1006076A2 (pt) composicoes farmaceuticas
IT1399353B1 (it) Procedimento per la produzione di cioccolata
BR112012000679A2 (pt) diagnóstico de uma doença parasitária como a leishmaniose utilizando um extrato de proteína ribossômica (epr)
DE102009036424A8 (de) Endoskopisches Instrument

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]